St. Vincents Comprehensive Cancer Center — New York, New York

St. Vincents Comprehensive Cancer Center is a clinical research site located in New York, New York, United States 10011.

Crixeo Health Trust Score: 78/100 (FAIR). This profile has not yet been claimed by the site owner.

St. Vincents Comprehensive Cancer Center has participated in 10 clinical trials.

Therapeutic areas: Fallopian Tube Cancer, Metastatic Cancer, Ovarian Cancer.

Sponsors: Genzyme, a Sanofi Company, Celgene Corporation, SWOG Cancer Research Network.

Sponsor Feasibility Report

Trust Score: 78/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for St. Vincents Comprehensive Cancer Center?

St. Vincents Comprehensive Cancer Center has a Crixeo Trust Score of 78/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has St. Vincents Comprehensive Cancer Center conducted?

St. Vincents Comprehensive Cancer Center has 10 clinical trials on record. Their work covers Fallopian Tube Cancer, Metastatic Cancer, Ovarian Cancer.

Is St. Vincents Comprehensive Cancer Center accredited by Crixeo Health?

Yes — St. Vincents Comprehensive Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about St. Vincents Comprehensive Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.